Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clonal analysis of gliomas.
Kattar MM, Kupsky WJ, Shimoyama RK, Vo TD, Olson MW, Bargar GR, Sarkar FH. Kattar MM, et al. Among authors: shimoyama rk. Hum Pathol. 1997 Oct;28(10):1166-79. doi: 10.1016/s0046-8177(97)90255-0. Hum Pathol. 1997. PMID: 9343324
Public assistance and survival equality in patients with EGFR mutation-positive lung cancer.
Uryu K, Imamura Y, Shimoyama R, Mase T, Fujimura Y, Hayashi M, Ohtaki M, Otani K, Hibino M, Horiuchi S, Fukui T, Fukai R, Chihara Y, Iwase A, Yamada N, Tamura Y, Harada H, Tsuya A, Okabe T, Fukuoka M, Minami H. Uryu K, et al. Among authors: shimoyama r. Jpn J Clin Oncol. 2024 Dec 1:hyae167. doi: 10.1093/jjco/hyae167. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39673402
Risk Factors for Adhesive Small Bowel Obstruction After Liver Cancer Surgery.
Yukawa N, Yamada T, Ichikawa D, Aoyama T, Kataoka K, Shioya T, Tamura T, Shimoyama R, Fukazawa A, Kumamoto K, Yamashita N, Hasegawa S, Saito S, Takemasa I, Fujita F, Taniai N, Kaibori M, Yoshida H. Yukawa N, et al. Among authors: shimoyama r. Cancer Diagn Progn. 2024 Nov 3;4(6):689-695. doi: 10.21873/cdp.10383. eCollection 2024 Nov-Dec. Cancer Diagn Progn. 2024. PMID: 39502609 Free PMC article.
Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01.
Hibino M, Imamura Y, Shimoyama R, Fukui T, Fukai R, Iwase A, Tamura Y, Chihara Y, Okabe T, Uryu K, Okuda T, Taguri M, Minami H. Hibino M, et al. Among authors: shimoyama r. Target Oncol. 2024 Nov;19(6):925-939. doi: 10.1007/s11523-024-01094-5. Epub 2024 Sep 20. Target Oncol. 2024. PMID: 39302602 Free PMC article.
104 results